Table 7.
Biochemical and Serologic Measures of Hepatic Dysfunction at Last Follow-up in the Patients Studied
| OT | Date of OLT | Total bilirubin (mg/dl) | ALT (IU) | GGT (IU) | AP (IU) | AMA
|
Diagnosis | Date of biopsy | |
|---|---|---|---|---|---|---|---|---|---|
| Preoperative | Postoperative | ||||||||
| 230 | 4–82 | 0.6 | 34 | 112 | 562 | 1:40 | 1:160 | No biopsy | |
| 280 | 2–83 | 1.2 | 107 | 511 | 473 | 1:1000 | 1:80 | Mild chronic rejection | 9–83 |
| 319 | 9–83 | 0.7 | 16 | 95 | 165 | 1:100 | Neg | No biopsy | |
| 350 | 1–84 | 0.5 | 96 | 309 | 114 | 1:100 | 1:160 | Reticuloendothelial and parenchymal cell iron deposition | 12–85 |
| 359 | 1—84 | 1.3 | 41 | 87 | 66 | 1:60 | Neg | No biopsy | |
| 361 | 2–84 | 0.8 | 125 | 142 | 198 | 1:40 | 1:40 | No biopsy | |
| 497 | 2–85 | 0.6 | 59 | 164 | 133 | 1:1000 | 1:100 | Chronic rejection; portal fibrosis | 4–85 |
| 507 | 3–85 | 0.3 | 107 | 58 | 201 | 1:10 | 1:10 | Acute rejection | 11–86 |
| 519 | 4–85 | 1.1 | 86 | 1510 | 622 | 1:160 | Neg | Chronic rejection; disappearing ducts | 7–85 |
| 550 | 6–85 | 1.3 | 423 | 232 | 140 | — | — | Fatty deposition | 4–86 |
| 585 | 8–85 | 0.7 | 42 | 225 | 88 | 1:300 | 1:50 | Mild cholestasis | 8–85 |
| 588 | 8–85 | 0.7 | 29 | 71 | 163 | 1:200 | 1:40 | Acute rejection | 9–85 |
| 596 | 8–85 | 0.8 | 31 | 96 | 270 | 1:10 | Neg | No biopsy | |
| Upper normals | 1.5 | 37 | 44 | 100 | <1:10 | ||||
ALT, alanine transaminase; AP, alkaline phosphatase; AMA, antimitochondrial antibody; GGT, y-glutamyl transferase; OLT, orthotopic liver transplantation; OT, the number given to liver transplant recipients.